Thursday, June 11, 2026

Patent directory Β· USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code β€” or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 1179 of 1,261
  1. US 6569889

    Amino ceramide-like compounds and therapeutic methods of use

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted May 27, 2003 Β· Expires May 22, 2023

    expired
  2. US 6569664

    Native TNF receptor releasing enzyme

    The Regents of the University of California Β· Granted May 27, 2003 Β· Expires May 22, 2023

    expired
  3. US 6569459

    Method of administration of paclitaxel-plasma protein formulation

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. Β· Granted May 27, 2003 Β· Expires May 22, 2023

    expired
  4. US 6569431

    Recombinant antibody fragments as autoantibody antagonists

    The Regents of the University of California Β· Granted May 27, 2003 Β· Expires May 22, 2023

    expired
  5. EP 1311248

    TRANSDERMALES THERAPEUTISCHES SYSTEM ZUR BEHANDLUNG DES RESTLESS-LEGS-SYNDROMS

    NEUROBIOTEC GMBH [DE] Β· Granted May 21, 2003 Β· Expires May 16, 2023

    expired
  6. US 6566324

    Preventing airway mucus production by administration of EGF-R antagonists

    The Regents of the University of California Β· Granted May 20, 2003 Β· Expires May 15, 2023

    expired
  7. US 6566358

    Cyclocarbamate derivatives as progesterone receptor modulators

    Ligand Pharmaceuticals Incorporated Β· Granted May 20, 2003 Β· Expires May 15, 2023

    expired
  8. US 6566098

    DNA encoding truncated hepatocyte growth factor variants

    The United States of America, as represented by the Department of Health and Human Services Β· Granted May 20, 2003 Β· Expires May 15, 2023

    expired
  9. US 6565853

    Recombinant virus

    The Secretary of State for Defence in Her Britannic Majesty's Government of the United Kingdom of Great Britain and Northern Ireland Β· Granted May 20, 2003 Β· Expires May 15, 2023

    expired
  10. US 6565827

    Radioimmunotherapy of lymphoma using anti-CD20 antibodies

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted May 20, 2003 Β· Expires May 15, 2023

    expired
  11. US 6565889

    Bilayer structure which encapsulates multiple containment units and uses thereof

    The Regents of the University of California Β· Granted May 20, 2003 Β· Expires May 15, 2023

    expired
  12. US 6566093

    Alphavirus cDNA vectors

    Bioption AB Β· Granted May 20, 2003 Β· Expires May 15, 2023

    expired
  13. US 6566500

    Compositions and methods for modifying toxic effects of proteinaceous compounds

    The Board of Regents of the University of Texas System Β· Granted May 20, 2003 Β· Expires May 15, 2023

    expired
  14. US 6566494

    Support material for solid phase organic synthesis

    Regents of the University of Minnesota Β· Granted May 20, 2003 Β· Expires May 15, 2023

    expired
  15. US 6566509

    Multivalent macrolide antibiotics

    Theravance, Inc. Β· Granted May 20, 2003 Β· Expires May 15, 2023

    expired
  16. US 6566372

    Bicyclic androgen and progesterone receptor modulator compounds and methods

    Ligand Pharmaceuticals Incorporated Β· Granted May 20, 2003 Β· Expires May 15, 2023

    expired
  17. US 6566342

    Gene therapy by secretory gland expression

    The Regents of the University of California Β· Granted May 20, 2003 Β· Expires May 15, 2023

    expired
  18. US 6566326

    Chemically modified hemoglobin for burn shock resuscitation

    The Regents of the University of California Β· Granted May 20, 2003 Β· Expires May 15, 2023

    expired
  19. US 6565831

    Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders

    ONCOLYTICS BIOTECH INC. Β· Granted May 20, 2003 Β· Expires May 15, 2023

    expired
  20. US 6566116

    Matrix metalloprotease

    Takeda Chemical Industries Ltd. Β· Granted May 20, 2003 Β· Expires May 15, 2023

    expired
  21. US 6562589

    AIB1, a novel steroid receptor co-activator

    The United States of America, as represented by the Department of Health and Human Services Β· Granted May 13, 2003 Β· Expires May 8, 2023

    expired
  22. US 6562988

    Methods and products relating to 16-HETE analogs

    Univ. of Texas System Board of Regents Β· Granted May 13, 2003 Β· Expires May 8, 2023

    expired
  23. US 6562942

    Methods for treatment of diabetes using peptide analogues of insulin

    Neurocrine Biosciences, Inc. Β· Granted May 13, 2003 Β· Expires May 8, 2023

    expired
  24. US 6562861

    Substituted cyclopentane and cyclopentene compounds useful as neuraminidase inhibitors

    BioCryst Pharmaceuticals, Inc. Β· Granted May 13, 2003 Β· Expires May 8, 2023

    expired

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search β€” best for looking up a specific filing or applicant portfolio slice.